KIRKLAND, WASHINGTON - August 19, 1999 - Radiant Research, a leading Site Management Organization (SMO), announces the establishment of a new site in Santa Rosa, California. Radiant Research - Santa Rosa is headed by Stephen W. Halpern, M.D., a leading authority in cardiology. Dr. Halpern has been conducting clinical trials for eight years. He is an accomplished writer and lecturer on a variety of subjects in cardiology and holds the position of Clinical Associate Professor of Medicine and Family Medicine with the University of California - San Francisco School of Medicine.

"Radiant Research, with its sophisticated business infrastructure and high-quality Leadership Team, will provide the resources needed to build and grow a top-notch multi-specialty research site with expertise in cardiology," commented Stephen Halpern, M.D., Medical Director of Radiant Research - Santa Rosa. "Placing this new site within the group of the best clinical research investigators in the country creates the strategic platform necessary for our success in the competitive marketplace."

"Establishment of Radiant Research - Santa Rosa is consistent with our strategy for greenfield site development based on expertise of leading researchers," stated Eric Hayashi, Vice President, Corporate Development of Radiant Research. "Dr. Halpern brings to Radiant a healthy entrepreneurial appetite, academic rigor, and down-in-the-trenches study conduct experience-a perfect mix for a greenfield site medical director."

"Radiant Research will continue to establish and grow new premier clinical research sites under the leadership of experienced investigators," said Mike Lester, President and CEO of Radiant Research. "Greenfield site development adds breadth and depth to Radiant's service offering and allows us to apply demonstrated best practices at new strategic locations."

                                                             ###

About Radiant Research
Based near Seattle, Washington, Radiant Research (radiantresearch.com) is a comprehensive clinical research and development company serving the biopharmaceutical and medical device industry. Radiant is comprised of more than 30 wholly-owned premier clinical research centers nationwide, employing over 500 clinical research professionals exclusively focused on providing professional, high quality study conduct and drug development services. In the past four years, Radiant has conducted more than 8,000 clinical trials across 18 therapeutic specialties.

Contact:
Michael K. Lester Chief Executive Officer RADIANT RESEARCH (425) 468-6200	Pamela M. Spaniac Chief Financial Officer RADIANT RESEARCH (425) 468-6200